Ligand validation:4PR9

PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate

PIO is a Ligand Of Interest in 4PR9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4PR9_PIO_A_1101	2%	68%	0.269	0.607	0.39	0.81	-	2	0	0	81%	0.8085
4PR9_PIO_E_1101	2%	71%	0.386	0.678	0.35	0.75	-	2	11	0	100%	0.91
4PR9_PIO_B_1101	1%	68%	0.337	0.602	0.4	0.81	-	2	0	0	79%	0.6455
5L0G_PIO_C_1201	1%	44%	0.382	0.687	1.01	1.21	1	4	6	0	51%	0.5106
5L0D_PIO_D_1202	1%	50%	0.367	0.582	0.68	1.24	-	5	0	0	55%	0.4426
4CQK_PIO_N_1048	97%	51%	0.068	0.983	0.94	0.97	2	2	3	0	100%	1
5VYP_PIO_N_101	68%	47%	0.158	0.971	1.17	0.91	6	2	2	0	100%	1
6CS9_PIO_B_101	58%	45%	0.131	0.911	1.21	0.96	6	2	4	0	100%	1
5KUM_PIO_A_401	35%	43%	0.159	0.928	0.74	1.52	-	8	0	0	55%	0.5532
3SPG_PIO_A_400	35%	41%	0.214	0.936	1.16	1.18	2	4	0	0	81%	0.8085

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.